Three months ended Nine months ended
September 30, September 30,
2009 2008 2009 2008
---- ---- ---- ----
Revenues:
Net sales $19,089 $13,042 $36,194 $29,841
Royalties 481,197 - 856,597 2,028
Licensing fees 266,282 266,281 1,298,844 798,844
Consulting fees 70,000 70,000 210,000 354,185
--------- --------- --------- ---------
Total
Revenues 836,568 349,323 2,401,635 1,184,898
Costs and expenses:
Research and
development 112,920 71,737 352,983 260,440
General and
administrative 1,176,885 866,574 3,484,341 2,840,346
--------- --------- --------- ---------
Total costs and
expenses 1,289,805 938,311 3,837,324 3,100,786
--------- --------- --------- ---------
Operating loss (453,237) (588,988) (1,435,689) (1,915,888)
Other income (expense):
Interest Income 24,140 31,511 28,685 89,314
Interest expense - 46,979 (39) 46,528
Other, net 600 104,203 (8,863) 108,730
--------- --------- --------- ---------
24,740 182,693 19,783 244,572
------- ------- ------- -------
Loss before benefit
for income tax (428,497) (406,295) (1,415,906) (1,671,316)
Income tax benefit 46,376 192,287
'/>"/>SOURCE BioSpecifics Technologies Corp. Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 Related biology technology :1.
BioSpecifics to Present at the 9th Annual Healthcare Conference of Acumen Bio Fin Rodman Renshaw LLC2.
BioSpecifics Technologies Corp. Announces Sale of Stock in Private Placement Offering3.
BioSpecifics Technologies Corp. Announces Repayment of Outstanding Loan4.
BioSpecifics Technologies Corp. Announces Sale of Stock in Private Placement Offering5.
BioSpecifics Technologies Corp. Announces Additional Sales of Stock in Private Placement Offering6.
BioSpecifics Technologies Corp. Reports Second Quarter 2008 Financial Results7.
BioSpecifics Technologies Corp. Buys Down Royalties for Peyronies Disease8.
BioSpecifics Technologies Corp. Announces Appointment of Dr. Matthew Geller to Board of Directors9.
BioSpecifics Technologies Corp. to Present at Piper Jaffray 20th Annual Health Care Conference10.
BioSpecifics Technologies Corp. Announces Listing on NASDAQ Global Market11.
BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2008 Financial Results